Abstract
Serum AFP, uE3, β-HCGare all non-invasive techniques able to identify pregnant women at high risk of Down's syndrome and neural tube defects (NTD). We collected 1017 sera from pregnant women (age range: 18–41 years; gestation: 15–21 weeks). It is important that to calculate Down's syndrome risk to be sure what population parameters in computer software are used, and how appropriate these are for the population being screened. Our results from the risky pregnancies show an acceptable agreement between the Triple tests and amniocentesis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
